On the other hand, IL-33 promotes a large number of inflammatory cells infiltrating into brain tissue in MS, activating a severe inflammatory response, and exerting a neurotoxic effect (Jafarzadeh et al., 2016). This evidence concerns the gene IL33 and myeloid sarcoma.